Study to Learn More About the Benefits and Side-effects of Drugs Rivaroxaban and Apixaban Compared to the Drug Warfarin for Stroke Prevention in Patients With Rapid and Irregular Heartbeat Which is Not Due to a Heart-valve Fault (Non-valvular Atrial Fibrillation) in the UK Routine Clinical Practice
Clinical trial NCT03847181 · COMPLETED
Trial details
- NCT number
- NCT03847181
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-02-28
- Primary completion
- 2020-10-31
- Enrollment
- 45164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.